secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K/A
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001493152-23-005097
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 1.01, 2.01, 5.02, 3.02, 9.01, 4.01, 2.03, 3.03, 5.01, 5.03, 5.05, 5.06
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical files amendment to add exhibits to business combination 8-K; no new operational news
--------------------------------------------------------------------------------

- Amendment No. 1 to 8-K filed solely to attach exhibits omitted from original Feb. 14, 2023 filing due to EDGAR server limits.
- Exhibits include business combination agreement, lock-up agreements, non-competition agreement, and indemnification agreements.
- No changes to the previously reported business combination terms or post-Closing capital structure.
- Pro forma financial information and comparative per share data referenced as Exhibit 99.1 but not provided in this text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223005097/0001493152-23-005097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223005097/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer